Sale!

CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO I Deficiency Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP11B2 gene plays a crucial role in the production of aldosterone, a hormone vital for regulating blood pressure and electrolyte balance. Hypoaldosteronism congenital due to CMO I (Corticosterone Methyloxidase I) deficiency is a rare genetic disorder affecting aldosterone synthesis, leading to symptoms such as salt loss, dehydration, and failure to thrive in infants. The condition results from mutations in the CYP11B2 gene, which encodes an enzyme essential for the final steps of aldosterone production.

To diagnose this condition, a genetic test targeting the CYP11B2 gene can be performed. This test is available at DNA Labs UAE, a facility equipped with advanced genetic testing technologies. The test cost is 4400 AED and is designed to identify mutations in the CYP11B2 gene that lead to CMO I deficiency and consequently hypoaldosteronism. Early diagnosis through this genetic test can facilitate timely management and treatment of the condition, significantly improving the patient’s quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test

Test Name:

CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test

Components:

Price: 4400.0 AED

Sample Condition:

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

3 to 4 Weeks

Method:

NGS Technology

Test Type:

Metabolic Disorders

Doctor:

General Physician

Test Department:

Genetics

Pre Test Information:

Clinical History of Patient who is going for CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoaldosteronism congenital due to CMO I deficiency

Test Details:

CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency is a genetic disorder that affects the production of aldosterone, a hormone involved in regulating salt and water balance in the body. This condition is caused by mutations in the CYP11B2 gene, which provides instructions for making an enzyme called aldosterone synthase. NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic mutations or variations in an individual’s DNA. It allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of an individual’s genetic makeup. In the case of CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency, NGS genetic testing can be used to identify mutations or variations in the CYP11B2 gene that may be responsible for the condition. This can help with diagnosis, genetic counseling, and potentially guide treatment decisions. It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing for this condition. They can provide further information and guidance on how to proceed with testing and any potential implications for the individual and their family.

Test Name CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP11B2 Gene Hypoaldosteronism congenital due to CMO I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypoaldosteronism congenital due to CMO I deficiency
Test Details

CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency is a genetic disorder that affects the production of aldosterone, a hormone involved in regulating salt and water balance in the body. This condition is caused by mutations in the CYP11B2 gene, which provides instructions for making an enzyme called aldosterone synthase.

NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic mutations or variations in an individual’s DNA. It allows for the simultaneous analysis of multiple genes or even the entire genome, providing a comprehensive view of an individual’s genetic makeup.

In the case of CYP11B2 gene hypoaldosteronism congenital due to CMO I deficiency, NGS genetic testing can be used to identify mutations or variations in the CYP11B2 gene that may be responsible for the condition. This can help with diagnosis, genetic counseling, and potentially guide treatment decisions.

It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of genetic testing for this condition. They can provide further information and guidance on how to proceed with testing and any potential implications for the individual and their family.